Skip to main content
OpenTrials

Clinical trial condition

Lymphoma, T-Cell, Cutaneous

Explore clinical trials studying Lymphoma, T-Cell, Cutaneous. Study availability and eligibility vary by location and protocol.

387 public trials 42 recruiting studies
Refine in advanced search Browse all conditions

Lymphoma, T-Cell, Cutaneous trial results

Completed

Study of the Safety and Tolerability of PCI-24781 in Patients With Lymphoma

NCT00724984

Conditions
Chronic Disease, Disease Attributes, Hematologic Diseases, +24 more
Locations
  • University of California, San Francisco San Francisco, California, United States
  • Northwestern University Medical School Chicago, Illinois, United States
  • Horizon Oncology Center Lafayette, Indiana, United States
  • University of Massachusetts Medical School Worcester, Massachusetts, United States
View Trial Details
Completed

Sunitinib Malate in Treating HIV-Positive Patients With Cancer Receiving Antiretroviral Therapy

NCT00890747

Conditions
AIDS-related Diffuse Large Cell Lymphoma, AIDS-related Diffuse Mixed Cell Lymphoma, AIDS-related Diffuse Small Cleaved Cell Lymphoma, +199 more
Locations
  • Jonsson Comprehensive Cancer Center Los Angeles, California, United States
  • Lombardi Comprehensive Cancer Center at Georgetown University Washington D.C., District of Columbia, United States
  • Northwestern University Chicago, Illinois, United States
  • AIDS - Associated Malignancies Clinical Trials Consortium Rockville, Maryland, United States
View Trial Details
Completed

Sibling Donor Peripheral Stem Cell Transplant or Sibling Donor Bone Marrow Transplant in Treating Patients With Hematologic Cancers or Other Diseases

NCT00438958

Conditions
Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +61 more
Locations
  • Fred Hutchinson Cancer Research Center Seattle, Washington, United States
  • Institute of Medical and Veterinary Science Adelaide, South Australia, Australia
  • Royal Melbourne Hospital Parkville, Victoria, Australia
  • Vancouver Hospital and Health Science Center Vancouver, British Columbia, Canada
View all 16 locations
View Trial Details
Completed

Vorinostat in Treating Patients With Metastatic or Unresectable Solid Tumors or Lymphoma and Liver Dysfunction

NCT00499811

Conditions
Adult Grade III Lymphomatoid Granulomatosis, Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma, +112 more
Locations
  • City of Hope Medical Center Duarte, California, United States
  • University of Southern California Los Angeles, California, United States
  • Emory University/Winship Cancer Institute Atlanta, Georgia, United States
  • National Institutes of Health Bethesda, Maryland, United States
View Trial Details

Related conditions